Global Medical Stock Price, News & Analysis

Global Medical REIT (NYSE:GMRE) reported its Q2 2025 financial results, highlighted by the appointment of Mark Decker, Jr. as CEO and the completion of a $69.6 million five-property medical portfolio acquisition. The company posted a net loss of $0.8 million ($0.01 per diluted share), while achieving AFFO of $16.6 million ($0.23 per share), up from $15.7 million in Q2 2024.

Key metrics include a 10.7% year-over-year increase in rental revenue to $37.9 million, portfolio occupancy of 94.5%, and total debt of $713.0 million with a 47.2% leverage ratio. The company maintained its full-year 2025 AFFO guidance of $0.89 to $0.93 per share and declared a quarterly dividend of $0.15 per share.

[ "Rental revenue increased 10.7% year-over-year to $37.9 million", "AFFO improved to $16.6 million ($0.23 per share) from $15.7 million year-over-year", "Completed $69.6 million portfolio acquisition at attractive 9.0% cap rate", "Strong portfolio occupancy of 94.5% with 2.1% weighted average annual rent escalations", "Favorable weighted average interest rate of 4.09% on total debt" ]

Global Medical REIT (NYSE:GMRE) has scheduled its second quarter 2025 financial results announcement for August 5, 2025, after market close. The company will host a conference call on August 6, 2025, at 9:00 a.m. Eastern Time, led by CEO Mark Decker, Jr., CFO Robert Kiernan, and CIO Alfonzo Leon.

Investors can access the call via webcast through GMRE's investor relations website or by dial-in. A replay will be available until August 20, 2025. GMRE operates as a net-lease medical REIT, focusing on acquiring and managing healthcare facilities leased to physician groups and healthcare systems.

Global Medical REIT (NYSE: GMRE) has appointed Mark Decker, Jr. as its new CEO and President, effective immediately. Decker succeeds Jeffrey Busch, who will transition to non-executive Chairman while remaining on the Board. The new CEO joins from Proterra Investment Partners, where he led their net lease real estate investment strategy. His prior experience includes serving as President, CEO, Trustee & CIO at Centerspace (NYSE:CSR) for nearly seven years, where he successfully transformed the company into a focused apartment owner-operator. Decker also spent two decades in real estate investment banking, including as Managing Director at BMO Capital Markets. The appointment reflects the Board's strategy to bring fresh perspective to portfolio management and growth initiatives.

Global Medical REIT (NYSE: GMRE) has announced its dividend distributions for Q2 2025. The company declared a quarterly cash dividend of $0.15 per share of common stock and unit, payable on July 9, 2025, to stockholders of record as of June 20, 2025. Additionally, GMRE announced a quarterly dividend of $0.46875 per share on its Series A Cumulative Redeemable Preferred Stock, payable on July 31, 2025, to preferred stockholders of record as of July 15, 2025, covering the period from April 30, 2025, through July 30, 2025.

Global Medical REIT (NYSE: GMRE) reported its Q1 2025 financial results, highlighting the completion of a previously announced $69.6 million five-property medical portfolio acquisition at a 9.0% cap rate. The company posted net income of $2.1 million ($0.03 per diluted share), up from $0.8 million in Q1 2024. FFO was $14.8 million ($0.20 per share), while AFFO reached $16.0 million ($0.22 per share). Portfolio metrics showed 95.6% occupancy across 4.9 million leasable square feet, generating $113.4 million in annualized base rent. The company reaffirmed its 2025 AFFO guidance of $0.89-$0.93 per share. During Q1, GMRE completed two property dispositions for $8.2 million, resulting in a $1.4 million gain. The company maintained a leverage ratio of 46.1% with total debt of $677.0 million at a weighted average interest rate of 3.84%.

Global Medical REIT (NYSE: GMRE), a net-lease medical REIT specializing in healthcare facility acquisitions, has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 results after market close on Wednesday, May 7, 2025, followed by a conference call on Thursday, May 8, 2025, at 9:00 a.m. Eastern Time.

The conference call will feature Chairman, President, and CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the webcast through the company's investor information website. A replay will be available from May 8, 2025, through May 22, 2025, with domestic dial-in number 1-844-512-2921 and international dial-in 1-412-317-6671 (passcode: 13752203).

Global Medical REIT (NYSE: GMRE) reported its Q4 and full-year 2024 financial results, highlighting significant portfolio expansion and strategic partnerships. The company acquired $80.3 million of single-tenant triple-net medical properties at an 8.0% cap rate and entered into a joint venture with Heitman.

Key Q4 2024 metrics include net income of $1.4 million ($0.02 per diluted share), FFO of $11.1 million ($0.15 per share), and AFFO of $15.8 million ($0.22 per share). Portfolio leased occupancy stood at 96.4% with annualized base rent of $110 million.

Notable developments include: entering a purchase agreement for a $69.6 million five-property portfolio at a 9.0% cap rate; completing seven dispositions generating $60.7 million in gross proceeds; and establishing a joint venture with Heitman, which manages over $48 billion in assets. The company provided 2025 AFFO guidance of $0.89-$0.93 per share and announced a Q1 2025 dividend of $0.21 per share.

Global Medical REIT (NYSE: GMRE), a net-lease medical REIT specializing in healthcare facilities, has scheduled its fourth quarter and year-end 2024 financial results announcement. The company will release its results after market close on Thursday, February 27, 2025, followed by a conference call on Friday, February 28, 2025, at 9:00 a.m. Eastern Time.

The conference call will feature Chairman, President, and CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the webcast through the company's investor information website. A replay will be available from 12:00 p.m. Eastern Time on February 28 until March 14, 2025.

Global Medical REIT (NYSE: GMRE), a net-lease medical real estate investment trust, has announced the availability of information regarding the federal income tax treatment of its 2024 dividends for both common and preferred stock. The information has been posted on the company's investor relations website.

The company advises stockholders to carefully review their Forms 1099 and other 2024 tax statements from their brokerage firms to ensure consistency with the posted information. GMRE also recommends that shareholders consult with professional tax advisors regarding their individual tax situations.